Paul Breillat

8PUBLICATIONS
60CO-AUTHORS
Haematological tumoursInnate immunityAutoimmunityRheumatology and arthritisOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 02, 2026
Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Paul Breillat, Samuel J Magaziner, Stéphane M Camus

|Jul 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Paul Breillat, Francesco Carbone, Emilie Lereclus

|Jan 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

|Jan 20, 2023
Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Paul Breillat, Alexis Mathian, Flore Rozenberg

|Oct 03, 2022
Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study.

Paul Breillat, Marie Jachiet, Yoan Ditchi

|Sep 05, 2022
Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Paul Breillat, Kuberaka Mariampillai, Paul Legendre

Pageof 2

Frequent Collaborators

4 joint publications

Pierre-Louis Tharaux

3 joint publications

Léa Dionet

3 joint publications

Olivier Kosmider

2 joint publications

Marie Templé